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ABSTRACT Poliovirus RNA polymerase requires a host 
factor to initiate RNA synthesis in vitro. The host factor was 
previously purified to near homogeneity from HeLa cells but 
was not assigned an enzymatic activity. This report describes 
the purification of a terminal uridylyltransferase that can act 
as host factor. By all criteria examined it is identical to the 
factor purified previously. It has the same molecular weight 
(68,000), chromatographic properties, and cellular localiza-
tion. We present evidence that terminal uridylyltransferase can 
add uridine residues to the 3' poly(A) end of virion RNA and 
that these anneal back to the poly( A) and form a hairpin primer 
for polymerase. 
Poliovirus has a 7500-nucleotide genome of positive polarity. 
Its 5'-terminal nucleotide is covalently linked to a protein 
(VPg), and the 3' end consists of a heterogeneous poly(A) 
tract averaging 75 nucleotides (1-6). Poliovirus encodes an 
RNA-dependent RNA polymerase, crude preparations of 
which can copy virion RNA in vitro (7, 8). Upon purification 
there is an absolute requirement for a primer (9-11). Added 
oligo(U) can anneal to the 3 '-terminal poly( A) of virion RNA 
and prime RNA synthesis. A protein fraction from uninfected 
cells can replace the oligo(U) primer and provide the initia-
tion function for the viral polymerase (9). This protein, "host 
factor,'' allows the viral polymerase to transcribe any 
poly(A)-containing RNA, with no clear specificity for virion 
RNA (11). 
We have reported preliminary results that suggested that 
host factor is a terminal uridylyltransferase (TUTase) (12). 
We proposed that, in vitro, host factor uridylylates the 
3'-terminus of virion RNA creating a hairpin primer recog-
nized by poliovirus RNA polymerase. To test this hypothesis 
we have attempted to separate host factor and uridylyltrans-
ferase activities by further purification. Although our initial 
characterization of TUTase used enzyme preparations from 
rabbit reticulocytes (12), host factor has been purified from 
HeLa cells (10, 13). It is apparently a Mr 68,000 cytoplasmic 
protein partitioned between ribosomal and soluble fractions. 
The approach taken here was to purify TUTase from the 
soluble phase of He La cells and test it for host factor activity. 
We find that host factor and TUT activities copurify through 
all procedures investigated. 
MATERIALS AND METHODS 
Many of the procedures used in this report have been 
described (12). 
Purification of TUTase from HeLa Cells. HeLa S3 cells 
were grown in suspension in Eagle's minimal essential 
medium (MEM) supplemented with 7% (voljvol) horse 
serum, by the Massachusetts Institute of Technology Cell 
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Culture Center. Starting material for purification was 6-9 x 
109 cells. Cells were swollen in 100 ml of buffer I [10 mM 
Hepes·KOH, pH 8.0/15 mM NaCl/1.5 mM MgC12/5 mM 
2-mercaptoethanol plus aprotinin (600 Kallikrein units/ml)] 
on ice, and disrupted with a Dounce homogenizer. The 
extract was centrifuged at 27,000 x g for 30 min at 2°C. The 
supernatant (cytoplasmic extract) was centrifuged at 200,000 
x g for 2 hr at 4°C yielding a clear S200 supernatant fraction. 
The S200 fraction was applied to a phosphocellulose 
column (Whatman P11), and the column was developed with 
a gradient of increasing salt. All TUTase activity bound to the 
column, and there was only one peak of activity in the eluent. 
TUTase activity eluted at about 360 mM KCl. 
Peak fractions from the phosphocellulose column were 
pooled and diluted with buffer A [20 mM Hepes·KOH, pH 
8.0/0.1 M EDTA/5 mM 2-mercaptoethanol/5% (voljvol) 
glycerol] to bring the concentration ofKCl down to ==:50 mM. 
This material was loaded onto a DEAE-Sephacel (Pharmacia) 
column. The column was washed thoroughly with buffer 
A/50 mM KCl, and protein was eluted with a gradient of 
increasing salt. All TUTase activity bound to the column, and 
there was only one peak of activity eluting between 80 and 
120 mM KCl. Fractions with the highest activity were pooled 
and concentrated. 
This material was applied to 10-30% glycerol gradients 
prepared in Buffer A/50 mM KCl, and these were centrifuged 
at 2°C in a Beckman SW41 rotor for about 40 hr at 40,000 rpm. 
Gradient fractions were collected from the bottom of the 
tube, and small portions were assayed for TUTase activity. 
Fractions with the highest activity were pooled. 
TUTase purified through the glycerol gradient was further 
purified using a poly(A)-agarose column [AGPoly(A), 
Pharmacia]. Proteins were eluted with a gradient of increas-
ing salt. TUTase eluted in a single peak between 100 and 200 
mM KCl; the exact position of the peak varied slightly with 
different batches of poly(A)-agarose. Fractions with the 
highest activity were pooled. Protein concentration was 
estimated by electrophoresing the sample through denaturing 
polyacrylamide gels and comparing band intensity with 
standards of known concentration. The material was made 
25% in glycerol and stored at -70°C. At this stage the enzyme 
could no longer tolerate more than several hours at 4°C. 
To assay TUTase activity in the cytoplasmic extract and 
S200 it was necessary to remove factors that inhibited the 
assay (presumably RNA) by passing the protein over a small 
DEAE column in buffer A containing 150 mM KCl. TUTase 
does not bind to DEAE at 150 mM KCl. 
Replicase Reaction. Replicase reactions were carried out as 
described (12), by using CTP as the labeled nucleotide. 
Purified HeLa TUTase at an estimated concentration of 
Abbreviations: TUTase, terminal uridylyltransferase; VPg, viral 
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about 1 p.g/ml replaced host factor and oligo(U). Reaction 
mixtures were incubated for 60 min. 
Isolation of Poly(A) from Virion RNA Incubated with 
TUTase. Virion RNA was incubated with rabbit reticulo-
cyte TUTase/host factor (12) under replicase reaction con-
ditions in the absence of poliovirus polymerase. The reticu-
locyte enzyme was a gift of Dan Levin. The [a-32P]UTP 
labeled product was digested with RNase T1 (cleaves after 
guanosine residues to leave mono- and oligonucleotides with 
a 3' phosphate group) and isolated by binding to poly(U) 
immobilized on filters as described by Spector and Baltimore 
(5). This material was subjected to nearest neighbor analysis 
(12). 
Reverse Transcriptase Assay. Reverse transcriptase reac-
tions were carried out in 50 J£1 of22 mM Tris·HCl, pH 8.5/2 
mM dithiothreitol/3 mM Mg(0Ac)2/27 mM NaCl/0.7 mM 
dATP/0.7 mM dGTP/0.7 mM dCTP/0.7 mM UTP/40 J£M 
dTTP /1 J£Ci of [ a-32P]dTTP (New England Nuclear) /2 units 
of RNasin RNase inhibitor (Promega Biotech, Madison, 
Wl)/0.3 p.g of virion RNA/1.5 units of avian myeloblastosis 
virus (AMV) reverse transcriptase (Life Sciences, St. Pet-
ersburg, FL), and, as indicated, either 20 p.g of oligo(U)/ml 
or about 0.5 J.'g (total protein) of rabbit reticulocyte 
TUTase/host factor (12). The mixtures were incubated at 
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30°C for 60 min. Products were spotted onto DE-81 paper and 
analyzed as for the TUTase assay. 
RESULTS 
TUTase has been identified as a contaminant in eukaryotic 
initiation factor 2 ( eiF2) preparations from rabbit reticulocyte 
ribosomal salt wash (12). These fractions of eiF2 could 
replace host factor in the in vitro poliovirus replicase reac-
tion. Preliminary experiments indicated that HeLa cells also 
contain a TUTase activity that is partially soluble and 
partially associated with ribosomes (12). To purify that 
activity further we first developed an assay that could 
quantitate the activity in crude fractions. This was accom-
plished by DEAE-Sephacel chromatography that removed 
apparent inhibitors (probably RNA). Using this treatment we 
found that 65% of the TUTase activity is soluble after high 
speed centrifugation (as found earlier for host factor; ref. 10) 
and chose to purify the soluble material. 
TUTase was then purified by conventional ion exchange 
chromatography and glycerol gradient centrifugation. Fig. 1 
shows the chromatographic profiles; Table 1 shows the 
recovery and purification at various steps. 
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FIG. 1. Purification of TUTase. Incorporation of [a-32P]UTP by TUTase during various purification steps starting from postribosomal 
supernatant is shown. (A) Chromatography of step 2 TUTase on phosphocellulose. Postribosomal supernatant (S200, step 2) was applied to a 
column (2.6 x 15 em) of phosphocellulose equilibrated with buffer A/50 mM KCl. Proteins were eluted with a 400-mllinear gradient of 50 mM 
to 1M KCl (----)in buffer A, fractions (about 5.2 ml) were collected, and activity was measured (x). Protein concentrations were measured 
using the BioRad assay and shown here as 00595 (e). An 00595 of 0.4 was approximately equal to 1 mg of protein/mi. (B) Chromatography 
of step 3 TUTase on OEAE-Sephacel. Pooled phosphocellulose peak material (step 3) was diluted and applied to a column (1.6 x 8 em) of 
OEAE-Sephacel equilibrated with buffer A/50 mM KCl. Proteins were eluted with an 80-mllinear gradient of 50-550 mM KCl in buffer A, 1.2-ml 
fractions were collected, and activity was measured. (C) Sedimentation of step 4 TUTase through a glycerol gradient. The peak fractions from 
OEAE-Sephacel chromatography (step 4) were pooled, and a portion was applied to a 10-30% glycerol gradient. Fractions of about 0.17 ml were 
collected and the activity was measured (o). The activity sedimented at approximately 4S. Although the gradient used here was analytical rather 
than preparative it is representative of the results of a number of experiments. (D) Chromatography of step 5 TUTase on poly(A)-agarose. The 
pooled peak material from glycerol gradients (step 5) was diluted with buffer A/50 mM KCl and applied to a column (0.9 x 15.6 em) of 
poly(A)-agarose equilibrated with buffer A/50 mM KCl. In other experiments smaller columns were used, with essentially the same results. 
Proteins were eluted with a 50-ml, 50-550 mM KCl gradient in buffer A(----), and 1.2-ml fractions were collected and assayed for activity. 
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Table 1. Purification of TUTase from HeLa cells 
Total protein, 
Step Vol, ml mg Total units Yield,% Fold 
1. Cytoplasmic extract 43 680 
2. Post-ribosomal supernatant 42 440 8780 (100) (1) 
3. Phosphocellulose 50 25 6155 70 12 
4. DEAE-Sephacel 5.5 1.7 4315 49 130 
5. Glycerol gradient 5.6 0.4 5915 67 740 
6. Poly(A)-agarose 1.2 0.08 3845 44 2400 
Quantitative data are shown for the six steps in a typical purification of TUTase from HeLa cells. 
Units are pmol of UTP incorporated during the standard reaction. Material from steps 1 and 2 was 
passed over DEAE-Sephacel to remove inhibitory substances before it was assayed. 
Enzyme fractions during purification were analyzed by 
electrophoresis through a denaturing polyacrylamide gel and 
silver nitrate staining (Fig. 2). Only one major protein band 
was present in step 6 HeLa TUTase. When fractions con-
taining enzyme activity from the glycerol gradient or poly(A)-
agarose steps were analyzed by electrophoresis, this Mr 
68,000 protein was the only protein whose distribution 
correlated with TUTase activity (data not shown). 
To assure that the l!.Ctivity we purified was really TUTase, 
the most highly purified fraction was incubated with several 
different RNA substrates, and [a-32P]UTP labeled products 
were analyzed. Products were digested with ribonuclease T2, 
which leaves 3' mononucleotides, and fractionated on a thin 
layer chromatogram (nearest neighbor analysis; ref. 12). 
Appearance of a labeled nucleotide indicates transfer of the 
a-phosphate of UTP to the 3' hydroxyl end of an RNA chain. 
Fig. 3 shows that the ends of polyribonucleotides can be 
uridylylated and that more than one UMP residue can be 
added, indicating that this TUTase is similar to that charac-
terized (12). 
Finally, step 6 He La TUTase was tested for activity in the 
in vitro poliovirus replicase reaction. The highly purified 
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FIG. 2. NaDodS04/PAGE of protein fractions during the puri-
fication of HeLa TUTase. Protein from each of the last four steps in 
the purification of HeLa TUTase was electrophoresed through a 
NaDodS04/polyacrylamide gel and was stained with silver nitrate. 
Lanes 1-3 contained about 1 J..Lg of protein. Lanes: 1, molecular size 
standards in kDa; 2, step 3 (phosphocellulose peak); 3, step 4 (DEAE 
peak); 4, step 5 (glycerol gradient peak); 5, step 6 [poly(A) agarose 
peak] . 
HeLa TUTase, like the rabbit reticulocyte TUTase described 
(12), did act as host factor (Table 2). This result is not 
surprising because TUTase and host factor have similar, if 
not identical, properties in all procedures employed for 
purification (results presented here; refs. 10 and 13). Other 
chromatographic resins were tested, including ATP-agarose, 
UTP-agarose, and poly(C)·poly(l)-agarose, and host factor 
and TUTase copurified on all (data not shown). 
Several additional experiments were carried out to inves-
tigate properties of TUTase that might be related to priming 
of RNA synthesis. In the following experiments, step 6 rabbit 
reticulocyte enzyme (12) was used rather than HeLa 
TUTase, because it offered a much more concentrated form 
of the enzyme. To determine whether a short stretch of 
oligo(U) could be added to poliovirion RNA by the TUTase 
activity, RNA was incubated with the enzyme under 
replicase reaction conditions in the absence of viral polymer-
ase. Digestion with RNase Tl liberated poly( A) from the viral 
RNA, which was then purified by binding to poly(U) immo-
bilized on glass fiber filters. The poly(A)-enriched material 
was digested with RNase T2 for nearest neighbor analysis. As 
shown in Fig. 4, the products were uridine 3'-phosphate and 
adenosine 3'-phosphate in a ratio of about four to one, 
poly 
(U) 
poly 
(A) 
poly 
(C) 
poly 
(AC) 
Ap 
• 
Cp 
Up 
FIG. 3. Nearest neighbor analysis of products of HeLa TUTase. 
Step 6 HeLa TUTase was incubated with [a-32P]UTP and different · 
RNA homo- and heteropolymers. The products were isolated and 
digested with RNase T2 for nearest neighbor analysis. RNase T2 
cleaves RNA nonspecifically to leave 3'-mononucleotides. The 
figure shows an autoradiogram of a chromatography plate. Ap, 
adenosine 3'-phosphate; Cp, cytidine 3'-phosphate; Up, uridine 
3' -phosphate. 
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Table 2. HeLa TUTase can act as host factor in the in vitro 
poliovirus replicase reaction 
[a-32P]CTP 
incorporated, pmol 
Reaction Experiment 1 Experiment 2 
Complete 
minus TUTase 
minus TUTase, minus polymerase 
minus polymerase 
1.03 
0.04 
<0.01 
<0.01 
0.86 
0.04 
<0.01 
<0.01 
Highly purified viral polymerase was incubated with step 4 HeLa 
TUTase in place of host factor under replicase reaction conditions. 
indicating that on average those molecules to which UMP 
residues were added accepted five residues. 
To examine whether or not TUTase could attach uracil 
nucleotides to the 5'-terminal peptide VPg, step 6 rabbit 
reticulocyte enzyme was incubated with synthetic VPg (14) 
and [a-32P]UTP under TUTase reaction conditions. Several 
concentrations of VPg were used, ranging from 30 to 150 JLM. 
At the end of the reaction, the material was analyzed by 
electrophoresis through a thin layer cellulose plate at pH 3.5. 
In this system, UTP migrates toward the anode and VPg 
(both uridylylated and nonuridylylated forms) migrates 
toward the cathode (15). No uridylylated VPg could be 
detected by autoradiography of the thin layer plate (data not 
shown). 
To assess the likelihood that a short stretch ofuridylic acid 
residues added to the 3' terminal poly(A) ofpoliovirion RNA 
could fold back and prime polymerization, we exploited a 
different nucleic acid polymerase activity. Retroviral reverse 
transcriptase synthesizes DNA copies of RNA molecules. 
This enzyme has been characterized extensively, and its 
primer requirements are well understood (16-18). The primer 
in vivo is a tRNA molecule that specifically hybridizes to an 
initiation site within the genome of the retrovirus (19, 20). In 
vitro either oligo(U) or oligo(dT) can be used to prime 
synthesis from 3' poly(A) in template RNA; oligo(dT) se-
quences as small as four nucleotides long are efficient primers 
(17). It seemed likely that if TUTase could synthesize a 
foldback primer for poliovirus polymerase, it should likewise 
synthesize a foldback primer for reverse transcriptase. Table 
Ap 
Up 
·} [a- 32P]·UTP 
degradation 
products 
FIG. 4. Addition ofUMP residues to the 3' end of virion RNA by 
TUTase. Virion RNA was incubated with TUTase as described in the 
text. Label associated with the 3' terminal poly(A) was analyzed by 
nearest neighbor analysis. The ratio of radioactivity in uridine 
3'-phosphate (Up) to adenosine 3'-phosphate (Ap) spots was about 
4:1. 
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Table 3. Stimulation of reverse transcriptase by TUTase 
Reaction 
Complete 
minus oligo(U) 
minus OOgo(U), plus TUTase 
minus oligo(U), minus reverse 
transcriptase, plus TUTase 
incorporated, pmol 
79.0 
1.2 
26.5 
0.8 
Complete reaction consists ofpoliovirion RNA template, oligo(U) 
primer, reverse transcriptase, UTP, and all four dNTPs. 
3 shows that this is the case. In the absence of a primer, 
reverse transcriptase incorporates very little dTTP. Oligo(U) 
can function as a primer for efficient synthesis. The step 6 
rabbit reticulocyte enzyme containing TUTase activity can 
replace oligo(U) as an initiator for reverse transcriptase, just 
as it can replace oligo(U) in the poliovirus polymerase assay. 
The step 6 rabbit reticulocyte enzyme alone cannot incorpo-
rate significant amounts of dTTP. These results support the 
hypothesis that it is the TUTase activity in step 6 rabbit 
reticulocyte enzyme that acts as host factor-it seems un-
likely that any other activity in this highly purified prepara-
tion could serve to initiate synthesis by two quite different 
polymerases. 
Another group reported that host factor was a double-
stranded RNA-dependent protein kinase (21). We could not 
detect kinase activity in step 6 TUTase from HeLa cells or 
step 6 enzyme from rabbit reticulocytes, although both of 
these preparations had very high host factor activity. Reac-
tions were carried out in the presence and absence of low 
levels of double-stranded RNA, with added highly purified 
eukaryotic initiation factor 2 (data not shown). We also tested 
authentic double-stranded RNA-dependent protein kinase 
from rabbit reticulocytes for host factor activity. In two 
independent experiments we could not see any stimulation of 
the replicase reaction (data not shown). These data do not 
support the hypothesis that double-stranded RNA-dependent 
protein kinase and host factor are the same enzymes. 
DISCUSSION 
The results presented here reinforce our original suggestion 
(12) that HeLa host factor is a TUTase. The two activities 
copurify through many different manipulations, have the 
same apparent molecular weight, and are distributed simi-
larly within the cell. Earlier data indicated that host factor 
alone was not capable of incorporating nucleotides (9). We 
believe that the discrepancy lies in the fact that TUTase must 
be highly concentrated to incorporate enough labeled UTP to 
give a strong signal when poliovirus RNA is used as a 
substrate. Sufficiently concentrated TUTase to produce a 
signal was first detected in eukaryotic initiation factor 2 
preparations (12). Host factor concentrations adequate for 
maximal stimulation of the in vitro replicase reaction, how-
ever, only show detectable TUTase activity when certain 
RNA molecules [such as olig~(U)] are used as acceptors. 
The model presented (1!) for the in vitro action of host 
factor is supported by the results reported here. It seems 
likely that host factor adds UMP residues to the 3' end of 
virion RNA, which can anneal to poly(A) and form a hairpin 
primer for RNA synthesis by viral polymerase. Five residues 
are added, on average, to the 3' end of virion RNA. A 
five-base-pair adenosine-undine stem may not be stable at 
30°C under the conditions of the in vitro replicase reaction. 
Nonetheless, TUTase preparations can also initiate for a 
different primer-dependent polymerase, reverse transcript-
ase. It seems likely that protein in the TUTase preparation 
(presumably the transferase itself) stabilizes the initiation 
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complex. Host factor (21) and TUTase (unpublished results) 
both bind to double-stranded RNA agarose resins better than 
to single-stranded RNA agarose resins. 
TUTases and poly(U) polymerases have been described in 
a variety of tissues and organisms, ranging from plants to 
humans (12, 22-32). Association with ribosomes has been a 
consistent theme. There is no known cellular process that 
would require this type of enzyme. Small RNAs transcribed 
by eukaryotic RNA polymerase III are known to carry short 
(2-5 nucleotides long) stretches of uridylic acid at their 3' 
termini during some phase in their life cycle (33, 34). 
Although these uridylic acid residues may be genetically 
encoded, in at least one case they are added posttranscrip-
tionally (35). A Mr 50,000 protein specifically binds small 
RNA molecules that have been uridylylated at the 3' end but 
does not bind the same molecules lacking poly(U) tails (33, 
36-38). The protein was initially identified as the antigen for 
a certain class of autoantibodies (''anti-protein La'') made by 
patients with the disease systemic lupus erythematosus (39). 
Lupus antibodies have been described that are directed 
against a variety of ribonucleoprotein particles (40). The 
anti-protein La subset is unique in that the RNA components 
of the particles are extremely heterogeneous, and may 
include all RNA polymerase III transcripts. The function of 
the La antigen is unknown, but it is possible that it is related 
to the function of TUTase. 
The results presented in this paper provide further evidence 
for our earlier suggestion that host factor is a TUTase that 
initiates poliovirus RNA synthesis in vitro by creating a hairpin 
primer for viral polymerase. Although other models have been 
proposed for initiation in vitro, we believe this is the most 
probable. The genome-linked protein, VPg, does not prime 
polymerization in this reaction (unpublished results). In con-
trast to the results of Morrow et al. (21), we fmd no protein 
kinase activity associated with host factor activity. These facts 
suggest that host factor-dependent RNA synthesis by poliovirus 
RNA polymerase is initiated by a TUTase activity and is highly 
analogous to oligo(U)-dependent RNA synthesis. 
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